Premium Information is available for this item - Upgrade for $1 a day
6550-01-379-8810
Primidone Control Set
6550013798810 013798810 9513-10
January 2023
2
Marketplace 6550-01-379-8810
Request a Quotation from participating marketplace vendors
Related Documents 6550-01-379-8810 4+ Documents (More...)
Primidone Control Set 6550013798810 013798810 Request a Quotation from participating marketplace
Primidone Control Set 6550013798810 013798810 Request a Quotation from participating marketplace
Restrictions 6550-01-379-8810
6550-01-379-8810 is a Primidone Control Set that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
End Users 6550-01-379-8810
- MOE Rule:
- V540
- Effective Date:
- 1 Sep 1993
- Turkey (ZW01)
- Effective Date:
- 1 May 2001
Approved Sources 6550-01-379-8810
- Part Number
- Manufacturer
- Status
- 9513-10
- Manufacturer
- 0ALT7 - Abbott Laboratories (Obsolete)
- Primary Buy
- Primary Buy
Datasheet 6550-01-379-8810
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- General Characteristics Item Description [TEXT]
- P3 Vials (2.5 Ml In Each Vial) Of Primidone In Human Serum; Vial L 2.55 - 3.45 Ug/Ml; Vial M 10.8 - 13.2 Ug/Ml; Vial H 18 - 22 Ug/Ml; Store At 2 - 8 C (35 - 46 F); For In Vitro Diagnostic Use; Sufficient For 50 Tests
NATO Stock Numbers Related to 6550-01-379-8810
Freight Information 6550-01-379-8810
6550-01-379-8810 has freight characteristics.. 6550-01-379-8810 has a variance between NMFC and UFC when transported by rail and the description should be consulted.